Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
01/2004
01/01/2004US20040002521 Antiinflammatory agents; metalloprotease inhibitor; antiarthritic agents; antiallergens; viricides
01/01/2004US20040002519 Mixture of hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, insulin elimination promoter and insulin sensitizer with carrier
01/01/2004US20040002518 Anticancer agents; tyrosine kinase inhibitor; wound healing agents
01/01/2004US20040002512 Alpha-substituted carboxylic acid derivatives
01/01/2004US20040002511 Novel pyrazolo[1,5-a]pyridine derivatives and their use as neurotransmitter modulators
01/01/2004US20040002508 Antitumor agents; anticancer agents; sexual disorders; cardiovascular disorders
01/01/2004US20040002507 Rho-kinase inhibitors
01/01/2004US20040002501 Modulate signal transduction; antitumor, anticancer agents, vision defects, antidiabetic agents, antiinflammatory agents
01/01/2004US20040002496 Compositions useful as inhibitors of protein kinases
01/01/2004US20040002494 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
01/01/2004US20040002493 Benzoic acid derivatives and pharmaceutical agents comprising the same as active ingredient
01/01/2004US20040002491 Melatonergic receptors
01/01/2004US20040002490 Melatonergic receptors
01/01/2004US20040002482 Androgen pharmaceutical composition and method for treating depression
01/01/2004US20040002481 Novel 4-dedimethylaminotetracycline derivatives
01/01/2004US20040002458 Pharmaceutical compositions and methods using natriuretic peptides
01/01/2004US20040002454 Administering polypeptides; cardiovascular disorders
01/01/2004US20040002449 METH1 and METH2 polynucleotides and polypeptides
01/01/2004US20040002439 Human voltage gated sodium channel beta1A subunit and methods of use
01/01/2004US20040002134 Novel nucleic acid sequences encoding human KIAA0768 protein-like and human protein PRO228-like polypeptides
01/01/2004US20040002113 Detection and treatment methods for type I diabetes
01/01/2004US20040001818 Prevention endothelial cell migration; antiproliferative agent; diaphorase inhibitor
12/2003
12/31/2003WO2004001037A1 Method of diagnosing risk of myocardial infarction
12/31/2003WO2004001022A1 Probiotic propionibacterium jensenii 702
12/31/2003WO2004001004A2 Membrane associated tumor endothelium markers
12/31/2003WO2004001002A2 Novel anticholesterol compositions and method for using same
12/31/2003WO2004000869A1 Glucocorticoid receptor ligands for the treatment of metabolic disorders
12/31/2003WO2004000854A1 Sulfur-containing phospholipid derivatives
12/31/2003WO2004000846A1 Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors
12/31/2003WO2004000842A1 Substituted 2,4-dihydro-pyrrolo (3, 4-b) -quinolin-9-one derivatives useful as phosphodiesterase inhibitors
12/31/2003WO2004000841A1 Hetero-bicyclic compounds
12/31/2003WO2004000840A2 Quinuclidine derivatives and pharmaceutical compositions containing the same
12/31/2003WO2004000839A1 Thiazole derivatives as phosphodiesterase iv inhibitors
12/31/2003WO2004000833A1 Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase
12/31/2003WO2004000832A1 1-[(indol-3-yl)carbonyl] piperazine derivatives
12/31/2003WO2004000831A1 Indole derivatives useful as histamine h3 antagonists
12/31/2003WO2004000819A1 New use of pyrimidine - or triazine- 2-carbonitiles for treating diseases associated with cysteine protease activity and novel pyrimidine-2-carbonitile derivatives
12/31/2003WO2004000817A2 Benzimidazole compounds and their use as estrogen agonists/antagonists
12/31/2003WO2004000813A1 Phenoxypyridine derivative or salt thereof
12/31/2003WO2004000808A2 N-substituted piperidine derivatives as serotonin receptor agents
12/31/2003WO2004000807A1 Cannabinoid receptor agonists
12/31/2003WO2004000805A1 Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof
12/31/2003WO2004000804A1 Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof
12/31/2003WO2004000803A1 Cationically substituted diphenyl azetidinones, method for their production, medicaments containing said compounds and use thereof
12/31/2003WO2004000791A1 Benzene derivative
12/31/2003WO2004000790A1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
12/31/2003WO2004000789A1 Amide linker peroxisome proliferator activated receptor modulators
12/31/2003WO2004000788A1 Ureido-substituted aniline compounds useful as serine protease inhibitors
12/31/2003WO2004000786A1 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
12/31/2003WO2004000785A2 Phenyloxyalkanonic acid derivatives as hppar activators
12/31/2003WO2004000781A2 Nitrooxyderivatives of cyclooxygenase-2 inhibitors
12/31/2003WO2004000762A2 Propionic acid derivatives and their use as hppars activators
12/31/2003WO2004000369A2 Method of magnetically manipulating a cell with magnetisable particles
12/31/2003WO2004000368A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
12/31/2003WO2004000353A1 Dichloroacetate in combination with cardioprotective or hemodynamic drugs
12/31/2003WO2004000348A1 Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases
12/31/2003WO2004000338A1 Propolis extract and process for producing the same, and propolis-extract-containing antihypertension drug, food preparation and propolis composition
12/31/2003WO2004000331A1 Organ arrest, protection, preservation and recovery
12/31/2003WO2004000324A1 Pharmaceutical compositions for the treatment of diseases related to neurotrophines
12/31/2003WO2004000322A1 Thiazine and oxazine derivatives as mmp-13 inhibitors for treating arthritis
12/31/2003WO2004000321A1 Thiazine and oxazine derivatives as mmp-13 inhibitors for treating arthritis
12/31/2003WO2004000315A1 Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as hppar activators
12/31/2003WO2004000309A1 The use of benzisoselenazolone compounds against ischemic myocardial damage
12/31/2003WO2004000307A1 Novel use of ansamycin antibiotics and method of screening novel angiogenesis inhibitor
12/31/2003WO2004000296A1 (2s)-2amino-a-{[2-(ethanimidoylamino) ethyl]thio}butanoic acid, a nitric oxide synthase inhibitor, in stabilized pharmaceutical dosage forms
12/31/2003WO2004000294A1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
12/31/2003WO2004000292A1 Composition comprising stabilised choline ascorbate
12/31/2003WO2004000286A1 Microcapsules for the delayed, controlled release of perindopril
12/31/2003WO2004000245A1 Promoter for uptake of basic amino acid into cell and cosmetic or drug composition
12/31/2003WO2004000214A2 Use of compounds having an amine nucleus in manufacture of a medicament useful for treating factor viia-associated conditions
12/31/2003WO2004000205A2 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
12/31/2003WO2004000204A2 Labelled somatostatin analogs backbone cyclized through metal complexation
12/31/2003WO2004000042A2 Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress
12/31/2003WO2003082893A8 Theraputic methods and uses of sapogenins and their derivatives
12/31/2003WO2003077832A3 Dexanabinol and dexanabinol analogs regulate inflammation related genes
12/31/2003WO2003074513A3 Indole amide derivatives and their use as glycogen phosphorylase inhibitors
12/31/2003WO2003068811A3 Cytotoxic t-cell epitopes from chlamydia
12/31/2003WO2003064638A3 Elongase gene and method for producing polyunsaturated fatty acids
12/31/2003WO2003064471A3 Gene for peripheral arterial occlusive disease
12/31/2003WO2003063758A3 Bicyclic cb2 cannabinoid receptor ligands
12/31/2003WO2003063576A3 Arylsulfonamidobenzylic compounds
12/31/2003WO2003060475A3 Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1h-benzoimidazole analogues
12/31/2003WO2003060077A3 Endothelial stem cells, populations, methods of isolation and use thereof
12/31/2003WO2003059288A3 Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds
12/31/2003WO2003059269A3 Acridone inhibitors of impdh enzyme
12/31/2003WO2003057203A3 Biomaterials based on hyaluronic acid for the anti-angiogenic therapy in the treatment of tumours
12/31/2003WO2003055916A3 Adiponectin fragments and conjugates
12/31/2003WO2003055912A3 Secreted proteins
12/31/2003WO2003039344A3 Methods and compositions for correction of cardiac conduction disturbances
12/31/2003WO2003020759A9 A caspase- 8 binding protein, its preparation and use
12/31/2003WO2003013499A3 Drugs for vasculopaties
12/31/2003WO2003010286A9 Nucleic acids, polypeptides, and methods for modulating apoptosis
12/31/2003WO2003006492A3 Biologically active peptides
12/31/2003WO2002078747A9 Pregabalin lactose conjugates
12/31/2003WO2002070562A3 Nuclear hormone receptor ligand binding domain
12/31/2003WO2002070068A3 Lipoxin analogs as novel inhibitors of angiogenesis
12/31/2003WO2002067971A3 Use of endostatin in the treatment of ocular neovascularization
12/31/2003WO2002060378A3 Substituted aryl compounds as cyclooxygenase-2 selective inhibitors, compositions and methods of use
12/31/2003WO2002047708A3 Selective cox-2 inhibition from edible plant extracts
12/31/2003WO2002047706A3 Selective cox-2 inhibition from plant extracts
1 ... 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 ... 1595